These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 12618498)

  • 21. Predicting features of breast cancer with gene expression patterns.
    Lu X; Lu X; Wang ZC; Iglehart JD; Zhang X; Richardson AL
    Breast Cancer Res Treat; 2008 Mar; 108(2):191-201. PubMed ID: 18297396
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development of a prediction model for lymph node metastasis in luminal A subtype breast cancer: the possibility to omit sentinel lymph node biopsy.
    Nakauchi C; Naoi Y; Shimazu K; Tsunashima R; Nishio M; Maruyama N; Shimomura A; Kagara N; Shimoda M; Kim SJ; Noguchi S
    Cancer Lett; 2014 Oct; 353(1):52-8. PubMed ID: 25016059
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The expression of stem cell protein Piwil2 and piR-932 in breast cancer.
    Zhang H; Ren Y; Xu H; Pang D; Duan C; Liu C
    Surg Oncol; 2013 Dec; 22(4):217-23. PubMed ID: 23992744
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prediction of cancer outcome with microarrays.
    Lee AH
    Lancet; 2005 May 14-20; 365(9472):1685; author reply 1686. PubMed ID: 15894094
    [No Abstract]   [Full Text] [Related]  

  • 25. A big trial for a new technology: TransBIG Project takes microarrays into clinical trials.
    Tuma RS
    J Natl Cancer Inst; 2004 May; 96(9):648-9. PubMed ID: 15126595
    [No Abstract]   [Full Text] [Related]  

  • 26. Identification of breast cancer metastasis-associated genes by chip technology.
    Evtimova V; Schwirzke M; Tarbé N; Burtscher H; Jarsch M; Kaul S; Weidle UH
    Anticancer Res; 2001; 21(6A):3799-806. PubMed ID: 11911250
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Made-to-order therapy using the gene profile].
    Kathmann W
    Dtsch Med Wochenschr; 2007 Nov; 132(48):p25. PubMed ID: 18033648
    [No Abstract]   [Full Text] [Related]  

  • 28. RBM5/H37 tumor suppressor, located at the lung cancer hot spot 3p21.3, alters expression of genes involved in metastasis.
    Oh JJ; Taschereau EO; Koegel AK; Ginther CL; Rotow JK; Isfahani KZ; Slamon DJ
    Lung Cancer; 2010 Dec; 70(3):253-62. PubMed ID: 20338664
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Microarrays in the clinic.
    Tillinghast GW
    Nat Biotechnol; 2010 Aug; 28(8):810-2. PubMed ID: 20697405
    [No Abstract]   [Full Text] [Related]  

  • 30. Prediction of cancer outcome with microarrays.
    Goldhirsch A; Gelber RD; Viale G; Colleoni M; Coates AS
    Lancet; 2005 May 14-20; 365(9472):1685-6; author reply 1686. PubMed ID: 15894095
    [No Abstract]   [Full Text] [Related]  

  • 31. Breast cancer molecular signatures as determined by SAGE: correlation with lymph node status.
    Abba MC; Sun H; Hawkins KA; Drake JA; Hu Y; Nunez MI; Gaddis S; Shi T; Horvath S; Sahin A; Aldaz CM
    Mol Cancer Res; 2007 Sep; 5(9):881-90. PubMed ID: 17855657
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Problems and prospects of fundamental research in breast cancer].
    Kurosumi M
    Nihon Rinsho; 2007 Jun; 65 Suppl 6():5-11. PubMed ID: 17682133
    [No Abstract]   [Full Text] [Related]  

  • 33. Breast cancer gene microarrays pass muster.
    Twombly R
    J Natl Cancer Inst; 2006 Oct; 98(20):1438-40. PubMed ID: 17047189
    [No Abstract]   [Full Text] [Related]  

  • 34. Differential gene expression patterns in HER2/neu-positive and -negative breast cancer cell lines and tissues.
    Wilson KS; Roberts H; Leek R; Harris AL; Geradts J
    Am J Pathol; 2002 Oct; 161(4):1171-85. PubMed ID: 12368191
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multi-group cancer outlier differential gene expression detection.
    Liu F; Wu B
    Comput Biol Chem; 2007 Apr; 31(2):65-71. PubMed ID: 17392030
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Integrating molecular profiling, histological type and other variables: defining the fingerprint of responsiveness to treatment.
    Viale G
    Breast; 2009 Oct; 18 Suppl 3():S32-6. PubMed ID: 19914539
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The molecular outlook.
    Caldas C; Aparicio SA
    Nature; 2002 Jan; 415(6871):484-5. PubMed ID: 11831227
    [No Abstract]   [Full Text] [Related]  

  • 38. An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients.
    Györffy B; Lanczky A; Eklund AC; Denkert C; Budczies J; Li Q; Szallasi Z
    Breast Cancer Res Treat; 2010 Oct; 123(3):725-31. PubMed ID: 20020197
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Global Analysis of miRNA-mRNA Interaction Network in Breast Cancer with Brain Metastasis.
    Li Z; Peng Z; Gu S; Zheng J; Feng D; Qin Q; He J
    Anticancer Res; 2017 Aug; 37(8):4455-4468. PubMed ID: 28739740
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Microarrays bring new insights into understanding of breast cancer metastasis to bone.
    Welch DR
    Breast Cancer Res; 2004; 6(2):61-4. PubMed ID: 14979907
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.